Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin(e6) immunoconjugates

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 56-64

  Del Governatore, M ^a,b   Hamblin, M R ^a   Piccinini, E E ^b   Ugolini, G ^b   Hasan, T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Laser; Photodynamic therapy; Photoimmunotherapy; Photosensitizer; Polylysine

Indexed keywords

ANION; CATION; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TALAPORFIN;

ARTICLE; CANCER CELL; COLONY FORMING CELL; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; RABBIT; TARGET CELL;

EID: 0033989729     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0877     Document Type: Article

References (48)

1. Bachor R, Shea CR, Gillies R and Hasan T (1991) Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. Proc Natl Acad Sci USA 88: 1580-1584
2. Barr H, Krasner N, Boulos PB, Chatlani P and Bown SG (1990) Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 77: 93-96
3. Benotli P and Steele G (1992) Patterns of recurrent colorectal cancer and recovery surgery. Cancer 70: 1409-1413
4. Bischoff P, Robert F and Donner M (1981) A comparative study of some growth characteristics and cell-surface properties of neoplastic cells. Br J Cancer 44: 545-552
5. Buchsbaum DJ, Langmuir VK and Wessels BW (1993a) Experimental radioimmunotherapy. Med Phys 20: 551-567
6. Buchsbaum DJ, Lawrence TS, Roberson PL, Heidorn DB, Ten Haken RK and Sleplewski Z (1993b). Comparison of 13H-and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts. Int J Radiat Oncol Biol Phys 25: 629-638
7. Clegg JA, Hudecz F, Mezo G, Pimm MV, Szekerke M and Baldwin RW (1990) Carrier design: biodistrihulion of branched polypeptides with a poly(L-lysine) backbone. Bioconjug Chem 1: 425-430
8. Cotten M, Langle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H and Birnstiel ML (1990) Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 87: 4033-4037
9. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889-905
10. Duncan R, Pratten MK and Lloyd JB (1979) Mechanism of polycation stimulation of pinocytosis. Biochim Biophys Acta 587: 463-475
11. 2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer 75: 837-844
12. Goff BA, Bamberg M and Hasan T (1991) Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res 51: 4762-4767
13. Goff BA, Hermanto U, Rumbaugh J, Blake J, Bamberg M and Hasan T (1994) Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model. Br J Cancer 70: 474-480
14. Goff BA, Blake J, Bamberg MP and Hasan T (1996) Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model. Br J Cancer 74: 1194-1198
15. Hamblin MR and Newman EL (1994) On the mechanism of the tumour-localising effect in photodynamic therapy. J Photochem Photobiol B 23: 3-8
16. Hamblin MR, Miller JL and Hasan T (1996) The effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res 56: 5205-5210
17. Hansen SH, Sandvig K and van Deurs B (1993) Molecules internalized by clathrin-independent endocytosis are delivered to endosomes containing transferrin receptors. J Cell Biol 123: 89-97
18. Hasan T (1992) Photosensitizer delivery mediated by macromolecular carrier systems. In Photodynamic Therapy: Basic Principles and Clinical Applicalinns, Henderson B and Dougherty T (eds), pp. 187-200. Marcel Dekker: London
19. Hasan T and Parrish JA (1996) Photodynamic therapy of cancer. In: Cancer Medicine, Holland JF, Frei El, Bast RCJ, Kufe DW, Morton DL and Weichselbaum RR (eds). pp. 739-751. Williams & Wilkins: Baltimore
20. Henderson BW and Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
21. Houston LL (1993) Targeted delivery of toxins and enzymes by antibodies and growth factors. Curr Opin Biotechnol 4: 739-744
22. Jain RK (1990) Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumours. Cancer Res 50: 814s-819s
23. Johnson DA, Briggs SL, Gutowski MC and Barton R (1995) Anti-tumor activity of CC49-doxorubicin immunoconjugates. Anticancer Res 15: 1387-1393
24. Kornguth SE, Kalinke T, Robins HI, Cohen JD and Turski P (1989) Preferential binding of radiolabeled poly-L-lysines to C6 and U87 MG glioblastomas compared with endothelial cells in vitro. Cancer Res 49: 6390-6395
25. Larson E, Howlett B and Jagendorf A (1986) Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 155: 243-248
26. Lilvinov SV, Velders MP, Bakker HA, Fleuren GJ and Warnaar SO (1994) Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437-446
27. McMurrick PJ and Nelson H (1997) Liver-directed therapies for gastrointestinal malignancies. Curr Opin Oncol 9: 367-372
28. Martin EW, Jr, Tuttle SE, Rousseau M, Mojzisik CM, O'Dwyer PJ, Hinkle GH, Miller EA, Goodwill RA, Oredipe OA, Barth RF & et al. (1986) Radioimmunoguided surgery: intraopcrative use of monoclonal antibody 17-1A in colorectal cancer. Hybridoma 5: S97-S108
29. Meredith RF, Khazaeli MB, Plott WE, Spencer SA, Wheeler RH, Brady LW, Woo DV and LoBuglio AF (1995) Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer. J Nucl Med 36 2229-2233
30. Mew D, Wat CK, Towers GH and Levy JG (1983) Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. J Immunol 130: 1473-1477
31. Pardridge WM, Bickel U, Buciak J, Yang J and Diagne A (1994) Enhanced endocytosis and anti-human immunodeficiency virus type 1 activity of anti-rev antibodies after cationization. J Infect Dis 169: 55-61
32. Pierce DL, Heindel ND, Schray KJ, Jetter MM, Emrich JG and Woo DV (1990) Misonidazole conjugates of the colorectal tumor associated monoclonal antibody 17-1A. Bioconjug Chem 1: 314-318
33. Pogrebniak HW, Matthews W, Black C, Russo A, Mitchell JB, Smith P. Roth JA and Pass HI (1993) Targetted phototherapy with sensitizer-monoclonal antibody conjugate and light. Surg Oncol 2: 31-42
34. Riethmuller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlinaier H, Hirche H, Pichlmayr R & et al. (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343: 1177-1183.
35. Saga T, Neumann RD, Heya T, Sato J, Kinuya S, Le N, Paik CH and Weinstein JN (1995) Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier. Proc Natl Acad Sci USA 92: 8999-9003
36. Sanz-Altamira PM, Spcncc LD, Huberman MS, Posner MR, Steele G, Jr, Perry LJ and Stuart KE (1997) Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 40: 770-775
37. Schmidt S, Wagner U, Ochr P and Krebs D (1992) Clinical use of photodynamic therapy in gynecologic tumor palients-antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure. Zentralbl Gynakol 114: 307-311
38. Shen WC and Ryser HJ (1978) Conjugation of poly-L-lysine to albumin and horseradish peroxidase: a novel method of enhancing the cellular uptake of proteins. Proc Natl Acad Sci USA 75: 1872-1876
39. Slinkin MA, Curtet C, Faivre-Chauvet A, Sai-Maurel C, Gestin JF, Torchilin VP and Chatal JF (1993) Biodistrihution of anti-CEA F(ab')2 fragments conjugated with ehelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance. Nucl Med Biol 20: 443-452
40. Speiser PP (1991 ) Nanoparticles and liposomes: a state of the art. Method Find Exp Clin Pharmacol 13: 337-342
41. Steele G, Jr and RavikumarTS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210: 127-138
42. Van Cutsem E (1996) A glimpse of the future: new directions in the treatment of colorectal cancer. Eur J Cancer 32A: S23
43. Van Hillegersberg R, Marijnissen JP, Kort WJ, Zondervan PE, Terpstra OT and Star WM (1992a) Interstitial photodynamic therapy in a rat liver metastasis model. Br J Cancer 66: 1005-1014
44. Van Hillegersberg R, Van den Berg JW, Kort WJ, Terpstra OT and Wilson JH (1992b) Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 103: 647-651
45. Veenhuizen RB, Marijnissen JP, Kenemans P, Ruevekamp-Helmers MC, Mannetje I.W, Helmerhorst TJ and Stewart FA (1996) Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma. Br J Cancer 73: 1387-1392
46. Veenhuizen RB, Ruevekamp MC, Oppelaar H, Ransdorp B, van de Vijver M, Helmerhorst TJ, Kenemans P and Stewart FA (1997) Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity. Photochem Photobiol 66: 389-395
47. Vrouenraets MB, Visser GW, Stewart FA, Stigter M, Oppelaar H, Postmus PE, Snow GB and van Dongen GA (1999) Development of metatetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res 59: 1505-1513
48. Yeh KA, Fortunato L, Hoffman JP and Eisenberg BL (1997) Cryosurgical ablation of hepatic metastases from colorectal carcinomas. Am Surg 63: 63-68